IP Verse

Peptide-Based Compounds As Inhibitors Of Neurotransmitter Secretion - EP2802337

The patent EP2802337 was granted to JI on Jan 20, 2021. The application was originally filed on Nov 7, 2012 under application number EP12848736A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2802337

JI
Application Number
EP12848736A
Filing Date
Nov 7, 2012
Status
Patent Maintained As Amended
Dec 18, 2020
Grant Date
Jan 20, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LUBRIZOL ADVANCED MATERIALSDec 21, 2018BRADLEY -

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS6169074
DESCRIPTIONUS6866856
INTERNATIONAL-SEARCH-REPORTUS2009226387
INTERNATIONAL-SEARCH-REPORTUS2010021510
OPPOSITIONEP1180524
OPPOSITIONUS2009226387
OPPOSITIONUS2010021510
OPPOSITIONUS2010215726
OPPOSITIONUS2010260823
OPPOSITIONUS2011206752
OPPOSITIONUS6380358
OPPOSITIONWO2009106338
SEARCHEP1180524
SEARCHEP2123673
SEARCHUS2009226387
SEARCHUS2010021510

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- Eur. J. Biochem., (19840000), vol. 138, pages 9 - 37-
DESCRIPTION- "International Cosmetic Ingredient Dictionary and Handbook", The Personal Care Products Council, (20100000), vol. 4-
DESCRIPTION- J. Chem., (19890000), vol. 264, pages 633 - 673-
INTERNATIONAL-SEARCH-REPORT- LAVEM CHINE PHARM COMPANY, "Product Catalogue.", COSMETIC PEPTIDE, ARGIRELINE ACETATE (ACETYL HEXAPEPTIDE-3), (2010), page 1, XP055166484-
OPPOSITION- Estée Lauder, "Eye Creme", GNPD, MINTEL, (20111100), Database accession no. 1671722, XP055543121-
OPPOSITION- PETERLIN et al., "Arginine Mimetic Structures in Biologically Active Antagonists and Inhibitors", Current Medicinal chemistry, (20060000), vol. 13, pages 3627 - 3648-
OPPOSITION- STANLEY H PINE, Organic Chemistry, Fifth Edition, McGraw-Hill, (19870000), pages 3pp, 832 - 833, XP055543109-
OPPOSITION- XIAOYI DU et al., "Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells", Journal of Pharmacological and Toxicological Methods, (20060000), vol. 54, pages 164 - 172, XP025015069
OPPOSITION- J RAUTIO et al., "Prodrugs: design and clinical applications", Nature Reviews Drug Discovery, (20080300), vol. 7, pages 255 - 270, XP055227338
OPPOSITION- C. BLANES-MIRA et al., "A synthetic hexapeptide (Argireline) with antiwrinkle activity", International Journal of Cosmetic Science, (20020000), vol. 24, pages 303 - 310, XP002675696
OPPOSITION- HARMS et al., "Arginine residues at internal positions in a protein are always charged", PNAS, (20111122), vol. 108, no. 47, pages 18954 - 18959, XP055543118
SEARCH- RAUTIO JARKKO ET AL, "Prodrugs: design and clinical applications", NATURE REVIEWS. DRUG DISCOVERY, NATURE PUBLISHING GROUP, GB, (20080301), vol. 7, no. 3, ISSN 1474-1784, pages 255 - 270, XP002579584 [Y] 1-15 * the whole document *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents